skip to main content
Refinado por: Nome da Publicação: Annals Of Oncology remover assunto: Tumors remover Science & Technology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)
Material Type:
Artigo
Adicionar ao Meu Espaço

Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)

Rochlitz, C. ; Ruhstaller, T. ; Lerch, S. ; Spirig, C. ; Huober, J. ; Suter, T. ; Bühlmann, M. ; Fehr, M. ; Schönenberger, A. ; von Moos, R. ; Winterhalder, R. ; Rauch, D. ; Müller, A. ; Mannhart-Harms, M. ; Herrmann, R. ; Cliffe, B. ; Mayer, M. ; Zaman, K.

Annals of oncology, 2011-01, Vol.22 (1), p.80-85 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

2
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
Material Type:
Artigo
Adicionar ao Meu Espaço

Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?

Regan, M.M. ; Pagani, O. ; Walley, B. ; Torrisi, R. ; Perez, E.A. ; Francis, P. ; Fleming, G.F. ; Price, K.N. ; Thürlimann, B. ; Maibach, R. ; Castiglione-Gertsch, M. ; Coates, A.S. ; Goldhirsch, A. ; Gelber, R.D.

Annals of oncology, 2008-07, Vol.19 (7), p.1231-1241 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Buscando em bases de dados remotas. Favor aguardar.